## NVMI: Nova Ltd. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.01 indicates fundamental undervaluation. Quality metrics strong (ROE 24%). Consistent execution (4/4 quarters beat estimates). Caution: overbought RSI (71).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($353.52)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Jefferies | $390 | $360 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Jefferies | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- FMR, LLC: 10.0% (+1.0%)
- Wasatch Advisors LP: 6.6% (-11.8%)
- Harel Insurance Inve: 4.9% (+6.4%)
- Migdal Insurance & F: 4.8% (-2.9%)
- Clal Insurance Enter: 4.5% (-14.3%)

### Key Risks

1. High beta (1.83) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +13.0% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.01 suggests fair value with growth premium. Forward P/E 39.8x stretched relative to 11% growth. Quality metrics strong (ROE 24%, margin 29%). Balance sheet: strong liquidity (4.6x). Analyst sentiment positive (1 raises, avg +8%). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.4B |
| Beta | 1.83 |
| 52W Range | $154.00 - $386.04 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.01 |
| Forward P/E | 39.8 |
| Current P/E | 44.1 |
| YoY Growth | 10.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 2.5% to 15.5% (+13.0% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (15.5% > 10.0%), caution on chasing. MRS_5 at 10.6% confirms short-term momentum alignment. AM_20 at 15.6% shows strong absolute momentum above own 20MA. Outperforming sector by 15.8pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.18), confirming momentum. RSI overbought at 71, risk of mean reversion. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 15.50% (CS: 99) | Strong |
| RSI_14 | 71.2 | Overbought |
| MACD Histogram | 4.18 | Bullish |
| vs SMA20 | 1.156x | Above |
| vs SMA50 | 1.189x | Above |
| vs SMA200 | 1.441x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $382.88
- **Stop Loss:** $353.52 (7.7% risk)
- **Target:** $441.60 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 39
- **Position Value:** $14,932.32
- **Portfolio %:** 14.93%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-12 (Est: $2.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.15 | $2.16 | +0.5% |
| 2025Q2 | $2.06 | $2.20 | +6.5% |
| 2025Q1 | $2.09 | $2.18 | +4.4% |
| 2024Q4 | $1.82 | $1.94 | +6.6% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*